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Abstract
Background: Chronic Kidney Disease is a major public health problem worldwide with enormous cost burdens on
health care systems in developing countries. We aimed to provide a detailed analysis of the processes and costs of
haemodialysis in Sri Lanka and provide a framework for modeling similar financial audits.
Methods: This prospective study was conducted at haemodialysis units of three public and two private hospitals
in Sri Lanka for two months in June and July 2010. Cost of drugs and consumables for the three public hospitals
were obtained from the price list issued by the Medical Supplies Division of the Department of Health Services,
while for the two private hospitals they were obtained from financial departments of the respective hospitals. Staff
wages were obtained from the hospital chief accountant/chief financial officers. The cost of electricity and water
per month was calculated directly with the assistance of expert engineers. An apportion was done from the total
hospital costs of administration, cleaning services, security, waste disposal and, laundry and sterilization for each
unit.
Results: The total number of dialysis sessions (hours) at the five hospitals for June and July were 3341 (12959) and
3386 (13301) respectively. Drug and consumables costs accounted for 70.4-84.9% of the total costs, followed by the
wages of the nursing staff at each unit (7.8-19.7%). The mean cost of a dialysis session in Sri Lanka was LKR 6,377
(US$ 56). The annual cost of haemodialysis for a patient with chronic renal failure undergoing 2-3 dialysis session
of four hours duration per week was LKR 663,208-994,812 (US$ 5,869-8,804). At one hospital where facilities are
available for the re-use of dialyzers (although not done during study period) the cost of consumables would have
come down from LKR 5,940,705 to LKR 3,368,785 (43% reduction) if the method was adopted, reducing costs of
haemodialysis per hour from LKR 1,327 at present to LKR 892 (33% reduction).
Conclusions: This multi-centered study demonstrated that the costs of haemodialysis in a developing country
remained significantly lower compared to developed countries. However, it still places a significant burden on the
health care sector, whilst possibility of further cost reduction exists.
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Background
Chronic Kidney Disease (CKD) is defined as either renal
damage or decreased renal function for three or more
months, and is characterized by progressive destruction
of renal mass with irreversible sclerosis and loss of
nephrons [1]. CKD requiring renal replacement therapy
is known as End-Stage Renal Disease (ESRD) [2]. Hae-
modialysis is one form of renal replacement therapy
available for such patients and for patients with Acute
Renal Failure (ARF) where dialysis is provided tempora-
rily till the recovery of renal function. CKD is becoming
a major public health problem worldwide, the average
annual cost for maintenance of ESRD therapy excluding
kidney transplantation was between US$ 70-75 billion
worldwide in 2001, and the predicted number of ESRD
patients will reach over 2 million by 2010 [3]. This enor-
mous cost of treatment leads to a large burden on
health care systems, particularly in developing countries
like Sri Lanka. * Correspondence: rana90210@yahoo.com
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CKD and its treatment recently due to the rapid increase
in prevalence. CKD of unknown etiology (CKDu) prevalent
in North-Central Province of the country, while diabetes
mellitus and hypertension are among the leading causes
identified elsewhere in the country [4]. The total number
affected by CKDu is unknown, however estimates suggests
that in excess of 6000 people were undergoing treatment
for this condition in 2005 [5]. In 2005, Anuradhapura
Teaching Hospital alone recorded 742 live discharges and
140 deaths due to CKDu [5]. Mortality due to genitourin-
ary diseases was the leading cause of death in many dis-
tricts, being the 11th leading cause of Mortality in the
country. In 2005, about 350 million rupees (4.6% of the
Annual Health Budget) was spent on the management of
patients with Renal Diseases [5]. Haemodialysis is the main
form of renal replacement therapy available to patients
with ESRD in Sri Lanka. This is offered free of charge at
public sector hospitals funded by the government of Sri
Lanka and at several private sector owned hospitals, where
the costs are borne by the patients. The increasing preva-
lence of ESRD has resulted in the demands for haemodialy-
sis far exceeding the service capacity of both public and
private sector health care services of Sri Lanka. In view of
this steady increase in the rate of entry of new patients into
haemodialysis programs, it is necessary to adopt measures
aimed at making the delivery of haemodialysis more effi-
cient and cost effective [6,7]. To achieve this objective it is
essential that the economic resources targeted towards this
area be scientifically reviewed.
The present era of health resource management rein-
forces the longstanding need to make the best use of avail-
able resources. Hence management and financial data are
being used to reshape health services worldwide and finan-
cial audits form a corner stone of these efforts. However,
results of such audits are often criticized as being inaccu-
rate, specific to an individual practices, difficult to under-
stand and reproduce. This most often occurs as a result of
the lack of knowledge and understanding of proper meth-
odologies involved in conducting such financial audits
among clinicians. There are no studies from Sri Lanka
examining the processes and costs involved in provision of
haemodialysis. The present study aims to provide a
detailed analysis of the processes and costs of haemodialy-
sis at public and private sector hospitals in Sri Lanka. In
addition, we intend to provide a framework that could be
utilized by clinicians for modeling similar financial audits.
Methods
Study setting
This prospective study was conducted at Haemodialysis
units of three public (government) hospitals and two
private hospitals in Sri Lanka for a period of two
months in June-July 2010. The three public hospitals
were; 1) The National Hospital of Sri Lanka (NHSL), 2)
Colombo South Teaching Hospital (CSTH) and 3) The
Kandy Teaching Hospital (KTH). The NHSL is the lar-
gest hospital in Sri Lanka with a bed strength of nearly
3300, while the KTH (the second largest hospital) and
CSTH has bed strengths of nearly 2300 and 1100
respectively [8]. The two private sector hospitals identi-
fied as Hospital ‘A’ and Hospital ‘B’ had bed strengths
of nearly 250 each. Permission to conduct the study was
obtained from the medical directors of the respective
hospitals. The study conformed to the Helsinki Declara-
tion and was conducted in accordance with local legisla-
tion. Ethical approval for the study was obtained from
the Ethics Review Committee of the Colombo South
Teaching Hospital, Kalubowila, Sri Lanka.
Data collection and analysis
Data for two consecutive months (June and July 2010)
were collected from the five dialysis units. A review of
audit data of each dialysis unit showed that the work-
load during the study period was similar with that of
previous months. Some data were collected prospec-
tively and others were obtained retrospectively from per-
usal of records maintained by the nursing staff. Initially
two members of the study team visited each dialysis
unit separately and performed an independent assess-
ment for a period of two weeks on the process of dialy-
sis and types of costs involved at each unit. This
primary data were analyzed and the costs items involved
under the categories of a) direct costs and b) indirect
costs were identified (Table 1). Workload, patient infor-
mation and consumables used were collected from the
registries maintained in the respective units.
Cost of the drugs and consumables for the three pub-
lic hospitals were obtained from the price list issued by
the Medical Supplies Division of the Department of
Health Services [9], while for the two private hospitals
they were obtained from the respective financial depart-
ments. Staff wages were obtained from the chief accoun-
tant/chief financial officer of each hospital. The cost of
electricity per month for each dialysis unit was calcu-
lated with the assistance of an engineer from Ceylon
Electricity Board (CEB). The total Watt consumption
per month at each dialysis unit was calculated taking
into account all electrical appliances at the unit, Watts
consumed by each appliance, duration of usage of appli-
ances per day and number of days the unit operates per
month. The monthly electricity consumption thus calcu-
lated was then used for calculation of the monthly elec-
tricity cost according to standard CEB rates.
T h ec o s to fw a t e rw a sc a l c u l a t e db yas i m i l a rd i r e c t
method with the assistance of an engineer from Ceylon
Water Board (CWB). The total monthly water con-
sumption at each dialysis unit was calculated by
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water usage per dialysis machines (as specified in the
product information leaflet) and number of machines at
each dialysis unit. This was then used for calculation of
monthly water costs according to standard CWB rates.
The usage of water for other purposes at the dialysis
units were negligible in comparison and were excluded.
The total hospital costs of administration, cleaning
services, security, waste disposal and, laundry and sterili-
zation were obtained from the chief accountant/chief
financial officer at each hospital. An apportion was done
from this total cost to obtain cost for each dialysis unit
based on the following method,
1. Cost of administration, cleaning services and
security - percentage surface area of the dialysis unit
in comparison to the total hospital surface area.
2. Waste disposal and, laundry and sterilization -
percentage monthly patient turnover at the dialysis
unit in comparison to the total hospital monthly
patient turnover.
The aim of the present study was to calculate the
operational costs of a haemodialysis unit thus capital
expenses, such as expenditure for buildings and furni-
ture were not included. A few recurrent expenditures,
such as maintenance, transport and mortuary costs were
negligible and were also not included in the calculation.
All data were double-entered and cross checked for con-
sistency. Data were analysed using SPSS version 14
(SPSS Inc., Chicago, IL, USA) statistical software
package.
Results
The total number of dialysis sessions at the five hospi-
tals for the months of June and July 2010 were 3341
and 3386 respectively, while the total hours of dialysis
were 12959 and 13301. The indication for a majority of
the dialysis were Chronic Renal Failure (June - 82.1%,
July - 81.2%). A summary of number dialysis, hours and
dialysis unit characteristics are provided in Table 2.
The percentage surface area of the dialysis units at
NHSL, KTH, CSTH, Hospital ‘A’ and Hospital ‘B’ were
0.06%, 0.45%, 0.164%, 0.5%, 1.0% respectively, while the
percentage patient turnover was 0.77%, 1.0%, 0.3%, 1.0%,
1.5% respectively. The breakdown of the costs of hae-
modialysis given as the average for the months of June
and July at each hospital is given in Table 3. Drug and
consumables costs accounted for 70.4% to 84.9% of the
total costs (NHSL - 78.9%, KTH - 74.0%, CSTH - 70.4%,
Hospital ‘A’ - 84.9%, Hospital ‘B’ - 79.7%), followed by
the wages of the nursing staff at each unit (7.8% to
19.7%). Both renal and non-renal nurses were attached
to the respective dialysis units, however there was no
difference in salary between the two group. The percen-
tage contribution to the total costs by each of the other
cost items was less than 4.0%.
The total cost per month for haemodialysis at the five
hospitals combined was LKR 22,491,384 (US$ 199,038),
hence the annual haemodialysis cost at these five hospi-
tals alone is nearly LKR 0.27 billion. The cost of haemo-
dialysis per hour at NHSL, KTH and CSTH were LKR
2,105 LKR 1,327 and LKR 2,923 respectively. Hospital
‘A’ and Hospital ‘B’ each charged their patients LKR
1,750 for an hour of haemodialysis. The actual cost of
haemodialysis per hour at Hospital ‘A’ and Hospital ‘B’
were LKR 1,692 and LKR 1,575 respectively. The costs
of a four hour haemodialysis session at NHSL, KTH,
CSTH, Hospital ‘A’ and Hospital ‘B’ were LKR 8,420,
LKR 5,308, LKR 11,692, LKR 6,768 and LKR 6,300
respectively.
Patients with ESRD in Sri Lanka usually undergo 2 to
3 haemodialysis sessions of four hours per week. The
mean cost of a four hour dialysis session in Sri Lanka
per patient was LKR 6,377 (US$ 56). The annual cost of
haemodialysis for a patient with chronic renal failure
undergoing 2-3 dialysis session of four hours duration
per week was LKR 663,208 - 994,812 (US$ 5,869 -
8,804).
At KTH facilities are available for the re-use of dialy-
zers, although this was not available during study period
due to logistical problems. However, when this pro-
gramme was active the dialyzers were re-used for five
dialysis sessions after sterilization. If this was carried out
Table 1 Cost items and categories associated with
provision of haemodialysis
Cost item Cost
category
Cost type
1. Administration Indirect cost Variable
indirect
2. Cleaning services Indirect cost Variable
indirect
3. Drugs and consumables Direct cost Variable direct
4. Electricity Direct cost Variable direct
5. Investigations Direct cost Variable direct
6. Laundry and sterilization Direct cost Variable direct
7. Maintenance (Building and
Equipment)
Direct cost Fixed direct
8. Security Indirect cost Variable
indirect
9. Staff wages Direct cost Variable direct
a. Doctors
b. Nurses
c. Minor staff (attendants and
labourers)
10. Waste disposal Indirect cost Variable
indirect
11. Water Direct cost Variable direct
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would have come down from LKR 5,940,705 to LKR
3,368,785 (43% reduction). This would reduce costs of
haemodialysis per hour from LKR 1,327 at present to
LKR 892 (33% reduction).
Discussion
The results of this study demonstrates that the cost of
haemodialysis in Sri Lanka is higher than in India [10]
and Sudan [11], but remained considerably less than
that of Brazil [12], Iran [13], Barbados [14], France [15],
Japan [16], Canada [17] and USA [18] (Table 4). The
differences noted in the reported cost in different stu-
dies are very high and cannot be explained solely in
terms of their annual per capita income between the
countries. A combination of factors play a role including
different management protocols, in-patient care, differ-
ent local labor costs, import duties, etc, for example,
while drugs and consumables cost constituted 70-85% of
overall expenses of dialysis in Sri Lanka, in Iran and
Greece it accounted for 12% and 53% of the cost respec-
tively [13,19]. In addition, the data on haemodialysis
costs are mostly from western developed countries,
while there is a relative lack of data from developing
countries and the Asian region. 4). However, since the
aim of the present study was to calculate the operational
costs of a haemodialysis unit thus capital expenses, such
as expenditure for buildings and furniture were not
included. This needs to be borne in mind when compar-
ing our finding with that of other countries that have
included these capital expenses.
In a country where the annual per capita income is
US$ 2,029 [20], comparatively the annual cost of dialysis
of US$ 5,869 - 8,804 is significantly high. This and the
increasing prevalence of ESRD place a significant burden
economically on the health care sector in Sri Lanka.
Hence, there is a timely necessity for cost reduction
methods. In the long term, the most important factor to
reduce the overall annual cost is to reduce the number
of patients with ESRD. This goal can be achieved by
preventing the progression of renal disease and
Table 2 Total number of dialysis sessions, dialysis hours & unit characteristics at each hospital
NHSL KTH CSTH Hospital ‘A’ Hospital ‘B’ Total
Dialysis sessions
June 562 1561 73 443 702 3341
July 668 1530 73 440 675 3386
Hours of dialysis
June 2094 6152 230 1772 2711 12959
July 2534 5946 240 1760 2821 13301
Dialysis machines 10 28 2 6 8 54
Hours of dialysis per machine
June 209.4 219.7 115 295.3 338.9 240.0
July 253.4 212.4 120 293.3 352.6 246.3
Doctors 0 2 0 0 4 6
Nursing staff 19 48 5 9 12 93
“Minor” staff 8 10 1 4 2 25
ARF - Acute Renal Failure, ESRD - End Stage Renal Disease, NHSL - The National Hospital of Sri Lanka, KTH - Kandy Teaching Hospital, CSTH - Colombo South
Teaching Hospital
Table 3 Costs of haemodialysis at each hospital
Average costs for June and July - LKR (US$)*
NHSL KTH CSTH Hospital
‘A’
Hospital
‘B’
Administration 139,734
(1,236)
52,213
(462)
3,936
(35)
32,156
(284)
138,909
(1,229)
Cleaning services 7,739
(68)
12,212
(108)
2,952
(26)
5,500
(49)
17,708
(157)
Drugs and
consumables
3,846,883
(34,043)
5,940,705
(52,573)
483,474
(4,278)
2,536,491
(22,447)
3,474,731
(30,750)
Electricity 153,214
(1,356)
364,425
(3,225)
26,150
(231)
82,220
(728)
132,192
(1,170)
Laundry and
sterilization
9,300
(82)
27,900
(247)
6,600
(58)
6,000
(53)
7,000
(62)
Security 1,336
(12)
4,883
(43)
1,148
(10)
9,500
(84)
17,039
(151)
Staff wages
Doctors 0
(0)
66,000
(584)
0
(0)
0
(0)
169,486
(1,500)
Nurses 513,000
(4,540)
1,296,000
(11,469)
135,000
(1,195)
234,000
(2,071)
367,113
(3,249)
Minor staff 192,000
(1,699)
240,000
(2,124)
24,000
(212)
62,400
(552)
14,940
(132)
Waste disposal 1,700
(15)
5,100
(45)
2,100
(18)
14,000
(124)
10,000
(88)
Water 7,512
(66)
18,147
(161)
910
(8)
5,298
(47)
9,770
(86)
Total 4,872,418
(43,119)
8,027,585
(71,041)
686,270
(6,073)
2,987,565
(26,439)
4,358,888
(38,574)
*1 US$ = Sri Lankan Rupees (LKR) 113, NHSL - The National Hospital of Sri
Lanka, KTH - Kandy Teaching Hospital, CSTH - Colombo South Teaching Hospital
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treatment of causative diseases.
The main contributor to cost in Sri Lanka was the
cost of drugs and consumables, thus strategies aimed at
reducing these costs would help to reduce annual cost
in the short term. One such method is the reuse of the
dialyzers implemented by KTH, which would success-
fully reduced the costs by nearly 35%. Reuse provides a
significant economic benefit, however recent reports
documenting certain pitfalls such as increased morbidity
and mortality and disease transmission, with reduced
dialyzer efficiency have cast doubts on the success of
this strategy [21].
The hourly cost of haemodialysis at each hospital was
inversely proportionate to the mean number of monthly
dialysis (Figure 1). The hourly cost of dialysis was high-
est at CSTH and lowest at KTH, with the lowest and
highest mean number of dialysis per month respectively.
The haemodialysis unit at CSTH mainly serves the pur-
pose of dialyzing in hospital patients with ARF or Acute
on Chronic Renal Failure while also handling transferred
patients from nearby smaller hospitals. These smaller
units elsewhere in the country helps to minimize the
workload of larger dialysis centers such as NHSL and
KTH, while improving the outcome of patients with
ARF by minimizing delays associated with transfers.
Table 4 Comparison of total haemodialysis cost per patient between countries
Country, year [Reference] Annual expenses per patient
(US$)
Cost items included
India, 2009 [10] $ 3,000 3, 4, 7, 9, 11, 10
Sri Lanka, 2010 $ 5,869 - 8,804 1, 2, 3, 4, 5, 6, 7, 8, 9
Sudan, 2010 [11] $ 6,847 3,7, 10, 12
Brazil, 2007 [12] $ 7,980 - 13,428 1, 2, 3, 4, 5, 7, 8, 9, 12
Iran, 2009 [13] $ 11,549 1,2, 3, 4, 7, 8, 9, 10, 11, 12, 13,
Barbados, 2004 [14] $ 17,029 1, 2, 3, 4, 5, 7, 9, 10
France [15] $ 34,452 - 39,089 1, 2, 4, 5, 7, 8, 9, 10, 12, 13
Japan, 2001 [16] $ 46,000 1, 2, 3, 4, 5, 6, 7, 8, 9, 12
Canada, 2002 [17] $ 42,057 - 51,252 1, 2, 3, 4, 5, 7, 9, 10, 12
USA, 2010 [18] $ 77,506 1, 2, 3, 4, 5, 7, 8, 9, 10, 11, 12
1- Administration; 2- Cleaning services; 3- Drugs and consumables; 4- Electricity; 5- Laundry and sterilization; 6- Security; 7- Staff wages; 8- Waste disposal; 9-
Water; 10- Capital expenses (buildings, machines, instruments, etc); 11- Maintenance and repair; 12- Hospitalization costs; 13- Personal costs to patients;
Figure 1 The mean number of haemodialysis sessions per month and dialysis cost per hour at each hospital.
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may be underutilized with respect to CKD patients
resulting in the overall costs being higher in comparison
to larger haemodialysis units. However the increased
workload at larger hospitals such as NHSL and KTH
has resulted in a dialysis machine operating in excess of
200 hours per month (Table 2). This may increase costs
associated with machine maintenance and breakdown
repair while in addition contributing to reduced effi-
ciency of haemodialysis.
Studies conducted in other countries have demon-
strated that kidney transplantation is the most cost-
effective treatment for end stage renal disease, offering
considerable savings and a drastic improvement in qual-
ity of life in these patients [22,23]. Considering the fact
that haemodialysis is the most common renal replace-
ment therapy for patients in Sri Lanka, it is highly
recommended that we try to improve our kidney trans-
plant programmes. Annual cost of Chronic ambulatory
peritoneal dialysis (CAPD) per patient is similar to the
cost of haemodialysis but is done infrequently as dialysis
fluid in not freely available. Patients’ perception on
CAPD is largely unknown. Therefore, further studies are
required in Sri Lanka, comparing the costs of the differ-
ent renal replacement therapy modalities.
This study has several limitations. We did not con-
sider costs which end stage renal disease imposes on
society in terms of production losses due to treatment
requirements, morbidity, mortality, and time spent to
care for patients. In addition personnel costs incurred
by patients were also not included in the study. The
lack of data from all renal replacement therapy provi-
ders in Sri Lanka prevented us from estimating the
overall disease burden caused by ESRD to the economy.
Erythropoietin and intravenous iron supplementation is
frequently offered to some patients with CKD during
dialysis in Sri Lanka. However, these were not offered to
all patients undergoing haemodialysis and thus were
excluded from the cost of consumables at each hospital.
Conclusion
This multi-centered study demonstrated that the costs
of haemodialysis in a developing country remained sig-
nificantly lower compared to developed countries. How-
ever, it still places a significant burden on the health
care sector, whilst possibility of further cost reduction
exists.
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